Wird geladen...
Renoprotective RAAS inhibition does not affect the association between worse renal function and higher plasma aldosterone levels
BACKGROUND: Aldosterone is elevated in chronic kidney disease (CKD) and may be involved in hypertension. Surprisingly, the determinants of the plasma aldosterone concentration (PAC) and its role in hypertension are not well studied in CKD. Therefore, we studied the determinants of aldosterone and it...
Gespeichert in:
| Veröffentlicht in: | BMC Nephrol |
|---|---|
| Hauptverfasser: | , , , , , , , |
| Format: | Artigo |
| Sprache: | Inglês |
| Veröffentlicht: |
BioMed Central
2017
|
| Schlagworte: | |
| Online Zugang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5738866/ https://ncbi.nlm.nih.gov/pubmed/29262813 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12882-017-0789-x |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|